HC Q study #23
See all studies
5/5
Positive
Early, Late
Million et al., Travel Med Infect Dis., 2020 May 5, doi:10.1016/j.tmaid.2020.101738 (Peer Reviewed)
Early Treatment of COVID-19 Patients With Hydroxych loroquine and Azithromycin: A Retrospective Analysis of 1061 Cases in Marseille, France
Retrospective 1061 patients. HC Q+AZ safe and results in a low fatality rate.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments:
Submit